Carolina Molecular
PrivateMomentum
Top 50%
of companies Caplight tracks
Company Overview
Carolina Molecular is a laboratory services (healthcare) company that provides molecular testing services for clinical diagnostics, discovery research, and product development.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Usage-Based SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Carolina Molecular Comparables
Compare Carolina Molecular with similar companies based on industry and business-model similarity.
Carolina Molecular Funding Rounds
Historical fundraising activity
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 22, 2026
Grew 38% QoQ, from 8 to 11 employees.
- Mar 2, 2026
Grew 57% QoQ, from 7 to 11 employees.
Carolina Molecular Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Carolina Molecular's valuation, stock price, and market status.